Maria Parshenkova
Press Releases
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
DOVER, Del., March 28, 2025 /PRNewswire/ -- Lomond Therapeutics Holdings, Inc. ("Lomond Therapeutics"), a clinical-stage biotechnology company dedicated to discovering and developing potentially best-in-class and first-in-class medicines for the treatment
